共 9 条
[1]
Ball A.P., Fox C., Ball M.E., Brown I.R.F., Willis J.V., Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients, Journal of Antimicrobial Chemotherapy, 17, pp. 629-635, (1986)
[2]
Bayer A., Gajewska A., Stephens M., Stark M.J., Pathy J., Pharmacokinetics of ciprofloxacin in the elderly, Respiration, 51, pp. 292-295, (1987)
[3]
Chin N-X, Novelli A., Neu H.C., In vitro activity of lomefloxacin (SC-47111, NY-198), a difluoroquinolone-3-carboxylic acid, compared with those of other quinolones, Antimicrobial Agents and Chemotherapy, 32, pp. 656-662, (1988)
[4]
Dobbs B.R., Gazely L.R., Campbell A.J., Edwards I.R., The effect of age on the pharmacokinetics of enoxacin, European Journal of Clinical Pharmacology, 33, pp. 101-104, (1987)
[5]
Lebel M., Bergeron M.G., Pharmacokinetics in the elderly, American Journal of Medicine, 82, pp. 108-114, (1987)
[6]
Morrison P.J., Mant T.G.K., Norman G.T., Robinson J., Kunka R.L., Pharmacokinetics and tolerance of lomefloxacin after sequential increasing oral doses, Antimicrobial Agents and Chemotherapy, 32, pp. 1503-1507, (1988)
[7]
Okezaki E., Makino E., Ohmichi K., Nagata O., Yamada T., Et al., Disposition and metabolism of NY-198, II: HPLC and bioassay studies of absorption and excretion in the dog, Chemotherapy (Tokyo), 16, pp. 138-143, (1988)
[8]
Shock N.W., Watkin D.M., Yiengst B.S., Nor A.H., Gaffney G.W., Et al., Age differences in the water content of the body as related to basal oxygen consumption in males, Journal of Gerontology, 18, pp. 1-8, (1963)
[9]
Wise R., Andrews J.M., Ashby J.P., Matthews R.S., In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents, Antimicrobial Agents and Chemotherapy, 32, pp. 617-622, (1988)